An immunohistochemistry-based study of breast cancer tissue samples obtained from 75 patients showed that a high RUNX2 level was significantly associated with poor prognosis, Ki-67 expression, and lymphatic metastasis [65]. Here, RUNX2 is linked to breast carcinoma.